Beam Therapeutics (BEAM) Total Debt (2019 - 2025)
Historic Total Debt for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $6.5 million.
- Beam Therapeutics' Total Debt fell 2261.9% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 2261.9%. This contributed to the annual value of $8.4 million for FY2024, which is 2222.22% down from last year.
- According to the latest figures from Q3 2025, Beam Therapeutics' Total Debt is $6.5 million, which was down 2261.9% from $3.9 million recorded in Q2 2025.
- Beam Therapeutics' Total Debt's 5-year high stood at $85.4 million during Q2 2021, with a 5-year trough of $3.9 million in Q2 2025.
- In the last 5 years, Beam Therapeutics' Total Debt had a median value of $13.6 million in 2023 and averaged $22.9 million.
- As far as peak fluctuations go, Beam Therapeutics' Total Debt skyrocketed by 59619.05% in 2021, and later plummeted by 8079.63% in 2022.
- Over the past 5 years, Beam Therapeutics' Total Debt (Quarter) stood at $42.2 million in 2021, then tumbled by 56.64% to $18.3 million in 2022, then plummeted by 40.98% to $10.8 million in 2023, then fell by 22.22% to $8.4 million in 2024, then decreased by 22.62% to $6.5 million in 2025.
- Its Total Debt stands at $6.5 million for Q3 2025, versus $3.9 million for Q2 2025 and $5.2 million for Q1 2025.